|
1.Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143 2.Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, et al. Plasma homocysteine as a risk factor for vascular disease. The european concerted action project. JAMA : the journal of the American Medical Association. 1997;277:1775-1781 3.Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:III27-32 4.Nozue T, Michishita I, Ishibashi Y, Ito S, Iwaki T, Mizuguchi I, Miura M, Ito Y, Hirano T. Small dense low-density lipoprotein cholesterol is a useful marker of metabolic syndrome in patients with coronary artery disease. Journal of atherosclerosis and thrombosis. 2007;14:202-207 5.Crawford DW, Blankenhorn DH. Arterial wall oxygenation, oxyradicals, and atherosclerosis. Atherosclerosis. 1991;89:97-108 6.Gleissner CA, Leitinger N, Ley K. Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis. Hypertension. 2007;50:276-283 7.Llorente-Cortes V, Badimon L. Ldl receptor-related protein and the vascular wall: Implications for atherothrombosis. Arteriosclerosis, thrombosis, and vascular biology. 2005;25:497-504 8.Galkina E, Ley K. Leukocyte influx in atherosclerosis. Current drug targets. 2007;8:1239-1248 9.Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially l-selectin dependent. The Journal of experimental medicine. 2006;203:1273-1282 10.Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 1988;8:348-358 11.Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241 12.Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circulation research. 2000;87:840-844 13.Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation. 2004;109:159-165 14.Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: The role of reparatory mechanisms. Diabetes care. 2011;34 Suppl 2:S285-290 15.Wanner A, Mendes ES. Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: A challenge for future research. American journal of respiratory and critical care medicine. 2010;182:1344-1351 16.Pober J, Cotran RS. What can be learned from the expression of endothelial adhesion molecules in tissues? Laboratory investigation; a journal of technical methods and pathology. 1991;64:301-305 17.Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of c-reactive protein on human endothelial cells. Circulation. 2000;102:2165-2168 18.Sawa Y, Ueki T, Hata M, Iwasawa K, Tsuruga E, Kojima H, Ishikawa H, Yoshida S. Lps-induced il-6, il-8, vcam-1, and icam-1 expression in human lymphatic endothelium. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 2008;56:97-109 19.Watson C, Whittaker S, Smith N, Vora AJ, Dumonde DC, Brown KA. Il-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clinical and experimental immunology. 1996;105:112-119 20.Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. The American journal of pathology. 1992;140:665-673 21.Cybulsky MI, Gimbrone MA, Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-791 22.Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circulation research. 2007;101:234-247 23.Qiu P, Pan PC, Govind S. A role for the drosophila toll/cactus pathway in larval hematopoiesis. Development. 1998;125:1909-1920 24.Chtarbanova S, Imler JL. Microbial sensing by toll receptors: A historical perspective. Arteriosclerosis, thrombosis, and vascular biology. 2011;31:1734-1738 25.Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature. 1997;388:394-397 26.Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004;303:1522-1526 27.Takeda K, Akira S. Toll-like receptors in innate immunity. International immunology. 2005;17:1-14 28.Gay NJ, Gangloff M. Structure and function of toll receptors and their ligands. Annual review of biochemistry. 2007;76:141-165 29.Botos I, Segal DM, Davies DR. The structural biology of toll-like receptors. Structure. 2011;19:447-459 30.O''Neill LA, Bowie AG. The family of five: Tir-domain-containing adaptors in toll-like receptor signalling. Nature reviews. Immunology. 2007;7:353-364 31.Akashi S, Saitoh S, Wakabayashi Y, Kikuchi T, Takamura N, Nagai Y, Kusumoto Y, Fukase K, Kusumoto S, Adachi Y, Kosugi A, Miyake K. Lipopolysaccharide interaction with cell surface toll-like receptor 4-md-2: Higher affinity than that with md-2 or cd14. The Journal of experimental medicine. 2003;198:1035-1042 32.Erridge C, Bennett-Guerrero E, Poxton IR. Structure and function of lipopolysaccharides. Microbes and infection / Institut Pasteur. 2002;4:837-851 33.Visintin A, Mazzoni A, Spitzer JA, Segal DM. Secreted md-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to toll-like receptor 4. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:12156-12161 34.Golias C, Tsoutsi E, Matziridis A, Makridis P, Batistatou A, Charalabopoulos K. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo. 2007;21:757-769 35.Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany HL, Murphy PM, Yoshie O. Molecular cloning of human eotaxin, an eosinophil-selective cc chemokine, and identification of a specific eosinophil eotaxin receptor, cc chemokine receptor 3. The Journal of biological chemistry. 1996;271:7725-7730 36.Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. The Journal of experimental medicine. 1996;183:2349-2354 37.Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, Mackay CR. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. The Journal of experimental medicine. 1996;183:2437-2448 38.Menzies-Gow A, Robinson DS. Eosinophil chemokines and their receptors: An attractive target in asthma? Lancet. 2000;355:1741-1743 39.Rankin SM, Conroy DM, Williams TJ. Eotaxin and eosinophil recruitment: Implications for human disease. Molecular medicine today. 2000;6:20-27 40.Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AE, Wells TN, Li D, Jeffery PK, Griffiths-Johnson DA, Williams TJ, Jose PJ. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo. The Journal of experimental medicine. 1997;186:601-612 41.Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, Baggiolini M. Eotaxin-2, a novel cc chemokine that is selective for the chemokine receptor ccr3, and acts like eotaxin on human eosinophil and basophil leukocytes. The Journal of experimental medicine. 1997;185:2171-2176 42.Min JW, Lee JH, Park CS, Chang HS, Rhim TY, Park SW, Jang AS, Shin HD. Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentration. Journal of human genetics. 2005;50:118-123 43.Elsner J, Petering H, Kluthe C, Kimmig D, Smolarski R, Ponath P, Kapp A. Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive g proteins in human eosinophils. European journal of immunology. 1998;28:2152-2158 44.Hansson GK. Immune mechanisms in atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2001;21:1876-1890 45.Kracht M, Saklatvala J. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine. 2002;20:91-106 46.Zubiaga AM, Belasco JG, Greenberg ME. The nonamer uuauuuauu is the key au-rich sequence motif that mediates mrna degradation. Molecular and cellular biology. 1995;15:2219-2230 47.Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS. Ared: Human au-rich element-containing mrna database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic acids research. 2001;29:246-254 48.Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene regulation by long noncoding rna. Journal of molecular biology. 2013;425:3723-3730 49.Hinman MN, Lou H. Diverse molecular functions of hu proteins. Cellular and molecular life sciences : CMLS. 2008;65:3168-3181 50.Peng SS, Chen CY, Xu N, Shyu AB. Rna stabilization by the au-rich element binding protein, hur, an elav protein. The EMBO journal. 1998;17:3461-3470 51.Myer VE, Fan XC, Steitz JA. Identification of hur as a protein implicated in auuua-mediated mrna decay. The EMBO journal. 1997;16:2130-2139 52.Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M. Hur regulates cyclin a and cyclin b1 mrna stability during cell proliferation. The EMBO journal. 2000;19:2340-2350 53.Guo X, Hartley RS. Hur contributes to cyclin e1 deregulation in mcf-7 breast cancer cells. Cancer research. 2006;66:7948-7956 54.Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. Concurrent versus individual binding of hur and auf1 to common labile target mrnas. The EMBO journal. 2004;23:3092-3102 55.Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, Gorospe M. Hur regulates p21 mrna stabilization by uv light. Molecular and cellular biology. 2000;20:760-769 56.Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J. The 3'' untranslated region of tumor necrosis factor alpha mrna is a target of the mrna-stabilizing factor hur. Molecular and cellular biology. 2001;21:721-730 57.Srikantan S, Gorospe M. Hur function in disease. Front Biosci (Landmark Ed). 2012;17:189-205 58.Xu N, Chen CY, Shyu AB. Versatile role for hnrnp d isoforms in the differential regulation of cytoplasmic mrna turnover. Molecular and cellular biology. 2001;21:6960-6971 59.Sarkar B, Lu JY, Schneider RJ. Nuclear import and export functions in the different isoforms of the auf1/heterogeneous nuclear ribonucleoprotein protein family. The Journal of biological chemistry. 2003;278:20700-20707 60.Gratacos FM, Brewer G. The role of auf1 in regulated mrna decay. Wiley interdisciplinary reviews. RNA. 2010;1:457-473 61.Wilson GM, Sutphen K, Chuang K, Brewer G. Folding of a+u-rich rna elements modulates auf1 binding. Potential roles in regulation of mrna turnover. The Journal of biological chemistry. 2001;276:8695-8704 62.Sirenko O, Bocker U, Morris JS, Haskill JS, Watson JM. Il-1 beta transcript stability in monocytes is linked to cytoskeletal reorganization and the availability of mrna degradation factors. Immunology and cell biology. 2002;80:328-339 63.Lafon I, Carballes F, Brewer G, Poiret M, Morello D. Developmental expression of auf1 and hur, two c-myc mrna binding proteins. Oncogene. 1998;16:3413-3421 64.Shyu AB, Belasco JG, Greenberg ME. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mrna decay. Genes & development. 1991;5:221-231 65.Nakamaki T, Imamura J, Brewer G, Tsuruoka N, Koeffler HP. Characterization of adenosine-uridine-rich rna binding factors. Journal of cellular physiology. 1995;165:484-492 66.Fellows A, Griffin ME, Petrella BL, Zhong L, Parvin-Nejad FP, Fava R, Morganelli P, Robey RB, Nichols RC. Auf1/hnrnp d represses expression of vegf in macrophages. Molecular biology of the cell. 2012;23:1414-1422 67.Guo X, Gourronc F, Audic Y, Lyons-Levy G, Mitchell T, Hartley RS. Elra and auf1 differentially bind cyclin b2 mrna. Biochemical and biophysical research communications. 2008;377:653-657 68.Lin S, Wang W, Wilson GM, Yang X, Brewer G, Holbrook NJ, Gorospe M. Down-regulation of cyclin d1 expression by prostaglandin a(2) is mediated by enhanced cyclin d1 mrna turnover. Molecular and cellular biology. 2000;20:7903-7913 69.Mazan-Mamczarz K, Kuwano Y, Zhan M, White EJ, Martindale JL, Lal A, Gorospe M. Identification of a signature motif in target mrnas of rna-binding protein auf1. Nucleic acids research. 2009;37:204-214 70.Amann BT, Worthington MT, Berg JM. A cys3his zinc-binding domain from nup475/tristetraprolin: A novel fold with a disklike structure. Biochemistry. 2003;42:217-221 71.Lagnado CA, Brown CY, Goodall GJ. Auuua is not sufficient to promote poly(a) shortening and degradation of an mrna: The functional sequence within au-rich elements may be uuauuua(u/a)(u/a). Molecular and cellular biology. 1994;14:7984-7995 72.Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M. Mapkap kinase 2 is essential for lps-induced tnf-alpha biosynthesis. Nature cell biology. 1999;1:94-97 73.Necela BM, Cidlowski JA. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proceedings of the American Thoracic Society. 2004;1:239-246 74.Raineri I, Wegmueller D, Gross B, Certa U, Moroni C. Roles of auf1 isoforms, hur and brf1 in are-dependent mrna turnover studied by rna interference. Nucleic acids research. 2004;32:1279-1288 75.Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mrna stability. Molecular and cellular biology. 2001;21:6461-6469 76.Korhonen R, Linker K, Pautz A, Forstermann U, Moilanen E, Kleinert H. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the jun n-terminal kinase. Molecular pharmacology. 2007;71:1427-1434 77.Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, Lefrancois L, Li Z. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity. 2007;26:215-226 78.Takahashi K, Shibata T, Akashi-Takamura S, Kiyokawa T, Wakabayashi Y, Tanimura N, Kobayashi T, Matsumoto F, Fukui R, Kouro T, Nagai Y, Takatsu K, Saitoh S, Miyake K. A protein associated with toll-like receptor (tlr) 4 (prat4a) is required for tlr-dependent immune responses. The Journal of experimental medicine. 2007;204:2963-2976
|